IFIH1 and myositis disease: The anti-MDA5 autoantibody JDM subgroup has less notable myositis with MMT <225/260 (0/8, 0.0%) and more cutaneous ulceration and interstitial lung disease (both 7/10, 70.0%) (Additional file 1: Table S2).